Your browser doesn't support javascript.
loading
Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity.
Carleton, B C; Ross, C J; Bhavsar, A P; Amstutz, U; Pussegoda, K; Visscher, H; Lee, J W; Brooks, B; Rassekh, S R; Dubé, M-P; Hayden, M R.
Afiliação
  • Carleton BC; 1] Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada [2] Department of Pediatrics, Division of Translational Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's H
  • Ross CJ; 1] Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada [2] Department of Pediatrics, Division of Translational Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's H
  • Bhavsar AP; Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
  • Amstutz U; 1] Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada [2] Department of Pediatrics, Division of Translational Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada [3] Pharmaceutical Outcomes Programme, BC Children's H
  • Pussegoda K; Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
  • Visscher H; Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
  • Lee JW; 1] Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Brooks B; Audiology and Speech Pathology Department, British Columbia Children's Hospital, Vancouver, British Columbia, Canada.
  • Rassekh SR; 1] Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada [2] Division of Pediatric Hematology/Oncology/Bone Marrow Transplant, Department of Pediatrics, British Columbia Children's Hospital, Vancouver, British Columbia, Canada.
  • Dubé MP; Montreal Heart Institute Research Centre and Université de Montreal, Montreal, Quebec, Canada.
  • Hayden MR; 1] Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada [2] Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
Clin Pharmacol Ther ; 95(3): 253, 2014 Mar.
Article em En | MEDLINE | ID: mdl-24193170
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Catecol O-Metiltransferase / Cisplatino / Perda Auditiva / Metiltransferases / Antineoplásicos Limite: Animals / Female / Humans / Male Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Catecol O-Metiltransferase / Cisplatino / Perda Auditiva / Metiltransferases / Antineoplásicos Limite: Animals / Female / Humans / Male Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2014 Tipo de documento: Article